genital warts
Recently Published Documents


TOTAL DOCUMENTS

1018
(FIVE YEARS 161)

H-INDEX

57
(FIVE YEARS 4)

2022 ◽  
Author(s):  
Laura Macca ◽  
Federica Li Pomi ◽  
Paolo Custurone ◽  
Mario Vaccaro ◽  
Francesco Borgia

Author(s):  
Anastasios Liberis ◽  
Georgios Pratilas ◽  
Roxani Dampali ◽  
Anastasia Vatopoulou ◽  
Stamatios Petousis ◽  
...  
Keyword(s):  

2021 ◽  
Vol 16 (1) ◽  
Author(s):  
Zahra Hosseini ◽  
Niloofar Seyrafi ◽  
Teamur Aghamolaei ◽  
Shokrollah Mohseni ◽  
Azin Alavi ◽  
...  

Abstract Background Genital warts (GWs) are highly prevalent among Iranian women. GWs are not only highly infectious but are also followed by severe adverse effects, including the development of cervical cancer. Therefore, the present study aimed to explore the effect of an educational intervention based on the health belief model (HBM) on the adoption of GWs preventive behaviors by married women in Bandar Abbas, a city in the south of Iran. Methods A quasi-experimental intervention was conducted between 2019 and 2020 among 150 women participants (75 as the intervention and 75 as the control group). The sampling method was multi-stage clustering. The required data was collected using a reliable and valid tripartite questionnaire which explored demographic information, awareness, and HBM constructs. A total number of 15 educational sessions were held, each 90 min long. The control group received only one 90-min session. The final follow-up was completed three months after the intervention in November 2020. Results The two research groups had no statistically significant differences in terms of awareness, perceived susceptibility, severity, benefits, barriers, and self-efficacy before the intervention (in the pre-test) (p > .05). After the educational intervention, the two groups showed statistically significant differences in all constructs except for the perceived benefits (p < .001). In the intervention group, in the pretest (before the intervention), the behavior score was 2.77 ± 2.59, which was increased to 3.73 ± .52 after the intervention (p < .001). In the control group, however, the difference was not statistically significant (p = 0.227). Conclusion The present findings showed that the educational intervention based on the HBM can improve the prevalence of GWs preventive behaviors in women. This education should be provided by experts at regular intervals in all healthcare centers.


Author(s):  
Lengbing Sun ◽  
Jiejie Lu ◽  
Ming Zhang ◽  
Xianxu Yang ◽  
Weiwei Wu ◽  
...  

2021 ◽  
Vol 16 ◽  
pp. 100251
Author(s):  
Laila Khawar ◽  
Hamish McManus ◽  
Tobias Vickers ◽  
Eric P.F. Chow ◽  
Christopher K Fairley ◽  
...  

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Enrique M Saldarriaga ◽  
Cesar P. Cárcamo ◽  
Joseph B. Babigumira ◽  
Patricia J. García

Abstract Objectives To estimate the cost of six different techniques used to treat Genital Warts and the annual average cost of treating a typical GW patient in Peru. To estimate the annual economic burden diagnosing and treating GW in the Peruvian public healthcare system. Methods We developed a prevalence-based, cost-of-illness study from the provider’s perspective, the healthcare facilities under the purview of Peruvian Ministry of Health. We used an activity-based costing approach. We conducted primary data collection in three regions in Peru and supplemented it with governmental data. Uncertainty of the costing estimates was assessed via Monte Carlo simulations. We estimated the average cost and associated confidence intervals for six treatment options – three topical and three surgical – and the overall cost per patient. Results The average treatment cost per patient was 59.9USD (95 %CI 45.5, 77.6). Given a population of 18.4 million adults between 18 and 60 years of age and a GW prevalence of 2.28 %, the annual cost of treating GW was 25.1 million USD (uncertainty interval 16.9, 36.6). Conclusions This study provides the first quantification of the economic burden of treating genital warts in Peru and one of the few in Latin America. The costing data did not include other healthcare providers or out-of-pocket expenditures, and hence we present a conservative estimate of the COI of GW in Peru. Our findings bring attention to the financial burden of treating GW, a vaccine-preventable disease.


Author(s):  
Sebastian A. Hoak

A clinical decision report using: Fife KH, Ferenczy A, Douglas JM Jr, et al. Treatment of external genital warts in men using 5% imiquimod cream applied three times a week, once daily, twice daily, or three times a day. Sex Transm Dis. 2001;28(4):226-231. https://doi.org/10.1097/00007435-200104000-00007 for a patient with genital warts and an unstable social support network.


Sign in / Sign up

Export Citation Format

Share Document